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Assay of erythrocyte uroporphyrinogen I synthase is an accepted diagnostic test for acute intermittent porphyria, particularly in those individuals who are asymptomatic or in whom the disease is not biochemically manifested by excretion of excess porphyrin precursor. The assay described is based upon a coupled-enzyme procedure in which added #{244}-aminolevulinicacid and its dehydratase present inerythrocytesare used to generate porphobilinogen as substrateforuroporphyrinogen synthase.Zinc and dithiothreitol are added with preincubation to give maximum activity and reproducibility. These agents also prevent inhibition by lead. Healthy young women had a mean activity of 40 nmol of porphyrin formed per milliliter of erythrocytes per hour, men an activity of 38 nmol/ml/h. Preparationof controlspecimens isdescribed.Thisassay gave within-day CVs ranging from 1.9 to 2.8%. Precautions in interpretation of results are discussed. 
Materials and Methods
Reagents
Blood diluent: Dissolve 0.2 ml of Triton X-100 surfactant in 100 ml of de-ionized water, and dissolve 28. Louis, Mo. 63178) in 100 ml of this buffer to yield 4 mmol/liter. Store at -20 #{176}C in convenient aliquots, which are stable for at least six weeks. Trichloroacetic acid: Dissolve 10 g of trichloroacetic acid in 100 ml of water. This solution is stable indefinitely.
Coproporphyrin standard:
Prepare a standard concentration of 76 nmol/liter by dissolving 5.0 ug of coproporphyrin (Sigma Chemical Co., or Porphyrin Products, Logan, Utah 84321) in 5.0 ml of 1.5 mol/liter HCL, heating, and then diluting to 100 ml with 1.5 mol/liter HC1. This solution is stable for at least a year when kept in a tightly stoppered container in the darkat4#{176}C.
Control: For quality control, centrifuge a suitable quantity of heparmnized whole blood, remove the plasma, and restore the original volume with 2 g/liter Triton X-100 solution containing neither zinc nor DTT. This specimen can be assayed repetitively to obtain between-batch mean and SD values. Assay individual aliquots concomitantly with diagnostic specimens.
Well-sealed aliquots stored at -20 #{176}C are stable for at least four months.
Specimens:
Heparinized whole blood, obtained by veni- The uncontaminated but refrigerated specimen is stable for at least one month; of course, the hematocrit must be determined before storage.
Procedure
The procedure, modified from the original report (2), begins with the addition of 1.0 ml of Triton X-100 reagent to three 15 X 75 mm test tubes, two for the specimen and one for the control. This Triton reagent should contain 1.0 mmol each of zinc sulfate and DTT per liter. Add 50 l of blood to each tube, mix by vortexing, stopper, and then preincubate all tubes in a covered water bath at 37 #{176}C for 30 mm. After this preincubation, 1.0 ml of phosphate-citrate buffer with no ALA substrate is added to the blank tube only, and 1.0 ml of buffered ALA substrate is added to each of the two specimen tubes.
The contents of all tubes are vortex-mixed, again stoppered, and then incubated in a covered water bath at 37 #{176}C. After 1 h, 2. 
Results
Analytical Variables
DTT concentration:
A concentration range of 10-2 to 10 mol/liter in the preincubation mixture was studied. 
Zinc sulfate concentration:
With zinc sulfate concentrations of 102 to iO mol/liter in the Triton reagent, disparate -, activities were obtained, depending upon preincubation. 2 Without preincubation, little or no stimulation was seen from 106 to 10 mol/liter, but at higher concentrations of i0 and 102 mol/liter there was a marked decrease of activity to 20% of control values, not appreciably altered by adding 1.0 mmol of DTT per liter. After 30-mm preincubation, zinc sulfate at 10 to 10 mol/liter enhanced activity by 12% (Figure 2 ). The latter concentration was thus chosen for routine use.
Preincubation:
The effect of preincubation periods up to 60 mm and in the presence of 1 mmol of DTT and zinc sulfate per liter contained in the Triton X-100 diluent were determined. Maximal enhancement of 8% was found with the 30-mm preincubation period.
Storage of specimens:
Addition of 1 mmol of DTT and zinc sulfate per liter to enzyme incubations resulted in complete restoration of URO-S activity in specimens that had been stored for as long as one week at room temperature and for at least one month at 4 #{176}C (Figure 3) . The frozen (-20 #{176}C) auquots of control lysate were restored to original activity after periods of as long as four months.
Normal Values
URO-S activity in 63 healthy college-age men and 67 healthy college-age women ( Figure 4 ) averaged 39 nmol of porphyrin formed per milliliter of erythrocytes per hour (SD = 5.1; range = 24-54). The mean activity for the women was 40 (range = 30-54), for the men 38 (range = 24-49). Our test results gave within-day coefficients of variation ranging from 1.9 to 2.8%.
A Case Study of Lead Interference
A patient with a past history of hemolytic anemia was ad- morphology showed poikilocytosis and basophilic stippling. Iron-loaded sideroblasts and a few ringed sideroblasts were noted in the bonemarrow biopsy. Subsequent investigation for lead poisoning showed a blood lead value of 880 pg/liter, protoporphyrin/ heme ratio 460 (reference mean = 10.8), urinary ALA 86 mg/24 h (range = 1.5-7.5 mg/24 h), and a urinary lead excretion of 54 ug/24 h. The URO-S activity in the absence of DTT and zinc was 7.0 nmol of porphyrin formed per milliliter of erythrocytes per hour, but this was restored to 85 by the addition of these two reagents. The low activity found without DTT and zinc suggests a falsely positive diagnosis of AlP. However, the abnormally high activity is consistent with the increased URO-S activity found in young erythrocytes that accompany an increased reticulocyte index.
Discussion
The incorporation of dithiothreitol as a reducing agent at a concentration of 1.0 mmol/liter in the Triton reagent (final concentration, 5 X 10 mol/liter) was found in this study to augment activity by approximately 8%, and an additional increment of approximately equal magnitude was found with 30-mm preincubation.Although one reportof a URO-S assay utilizing porphobiinogen as substrate failed to find enhanced porphyrin yield with the use of glutathione as the reducing agent (7), others have found a salutary effect of reducing agents on ALA-D activity. In one study, glutathione exerted maximum stimulation at 3.3 mmol/liter (8) , and in others glutathione (9) and DTT at 20 mmol/liter (10) increased the activities of this enzyme up to twice the control values. DTT also restored lead-inhibited enzyme activity to normal. These reducing agents were postulated to remove lead by chelation from the sulfhydryl groups of the enzyme (9). Other reports have noted the enhanced activity of ALA-D by zinc (11, 12) . Whereas this enzyme activity in erythrocytes and liver of rats varied directly with zinc intake, in vitro addition of zinc yielded only slight augmentation of activity, suggesting a requirement for zinc as a cofactor at the site of apoenzyme synthesis (13) . Others have found that addition of zinc to the ALA-D assay yields maximal activation at 0.1 mmol/liter (9) . In our experience, this concentration of zinc givesa rather constant 20% stimulation of ALA-D activity. 3 Even though the stimulation of activity afforded by DTT and zinc in fresh blood was slight, assurance of complete ac- to 28.6 nmol, but the Km remained increased at 1.9 X 10 mol/liter, suggesting continued competitive inhibition; however, under the conditions of the test with 1-h incubation, the ls reached and lead inhibition is obviated. Our kinetic measurements for URO-S in normal subjects were similar to those noted by others, with a mean Km of 12.3 mol/liter and a mean Vmax of 35.7 nmol (6). The respective values in AlP were 6.2 mol/liter and 18.0 nmol.
In interpreting URO-S activities, one must bear in mind the effect of mean age of the erythrocytes. Thus, any hematological abnormality that could shorten mean cell age could mask a decreased activity that would be diagnostic for AlP. Brocklehurst (19) has recently suggested using ALA at a substrate concentration of 20 imol/liter, to decrease the cost of the assay. We surmise that even a 10% increase in enzyme activity would justify the greater cost if optimum assay conditions are obtained as a result.
